Summary
The European Union’s medicines regulator on Friday granted a conditional authorisation for Madrigal Pharmaceuticals’ drug for a type of fatty liver disease, paving the way to make it the first treatment available for the condition in the region.
Source: Reuters on MSN.com
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
